Skip to content
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Menu
Search
Toggle Menu
Change Country
Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
Our COVID-19 Efforts
The Road to a Vaccine
About J&J
Our Credo
Our Leadership Team
Living Our Values
Code of Business Conduct
Corporate Reports
Diversity, Equity & Inclusion
ESG Policies & Positions
Innovation at J&J
J&J Health and Wellness Solutions
Office of the Chief Medical Officer
Veterans, Military & Military Families
Products
Consumer Health
MedTech
Pharmaceutical Products
Suppliers
Responsibility Supply Base
Supplier-Enabled Innovation
Supplier Resources
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
2022 Annual Meeting of Shareholders
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2021 Janssen Transparency Report
2021 Health for Humanity Report
ESG Investor Update
ESG Resources
Stock Information
Webcasts & Presentations
Investor Fact Sheet
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Sustainability
Close Countries Menu
Explore more Johnson & Johnson sites:
Australia
Argentina
Brazil
Canada
Consumer Health
Janssen
MedTech
Chile
China
Colombia
Costa Rica
Czech Republic
Ecuador
France
Germany
India
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
United Kingdom
United States
Uruguay
Venezuela
Close Search Menu
Search input
Share
Investor Information
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
Register Here
Johnson & Johnson to Participate in the Cowen 43
rd
Annual HealthCare Conference
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
NYSE: JNJ
$163.61
$0.00 (
0.000
%)
Day High
$164.56
Day Low
$162.90
Volume
2,134
Last Updated:
2/08/2023 04.10 PM
2022 Annual Meeting of Shareholders
2022 Annual Meeting of Shareholders
Annual Meeting Materials and Webcast
2022 ESG Investor Update Webcast
2022 ESG Investor Update Webcast
Learn More
Latest News Releases
Latest News
February 02, 2023
Johnson & Johnson to Participate in the Cowen 43
rd
Annual HealthCare Conference
Latest News
January 18, 2023
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
Financial
January 03, 2023
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023
See All News Releases
ON NOW
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
ON NOW
2021 Health for Humanity Report
2021 Health for Humanity Report
2021 Health for Humanity Report
ON NOW
2021 Janssen U.S. Transparency Report
2021 Janssen U.S. Transparency Report
2021 Janssen U.S. Transparency Report
ON NOW
2021 Annual Report
2021 Annual Report
2021 Annual Report
Investor Relations
ON NOW
Corporate Governance
Corporate Governance
Corporate Governance
ON NOW
SEC Filings
SEC Filings
SEC Filings
ON NOW
Pharmaceutical Pipeline
Pharmaceutical Pipeline
Pharmaceutical Pipeline
ON NOW
Stock Information
Stock Information
Stock Information
ON NOW
Webcasts & Presentations
Webcasts & Presentations
Webcasts & Presentations
ON NOW
Investor Fact Sheet
Investor Fact Sheet
Investor Fact Sheet
Quarterly Results
See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.
Learn More
Shareholder Tools
Email Alerts Subscription
RSS News Feeds
Investor FAQs
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Learn More
ESG Resources
Effective management of ESG matters is a business imperative.
Learn More
Contact Investor Relations
Questions? Please contact Investor Relations:
1-800-950-5089
Learn more about our Guidelines for Communication with the Investment Community (Reg FD)
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue